What it means
The Office on Women's Health estimates PCOS affects about 1 in 10 women of childbearing age. Diagnosis usually needs at least two of three features: irregular or absent ovulation, signs or lab evidence of high androgens, and many small follicles on the ovaries.
Common symptoms include irregular periods, excess facial or body hair, acne, thinning scalp hair, darkened skin in body folds, weight gain and trouble getting pregnant. PCOS is linked with type 2 diabetes, high blood pressure, abnormal cholesterol, sleep apnea and mood problems.
Many people with PCOS have insulin resistance. The Office on Women's Health notes that losing about 10% of body weight may make periods more regular and improve the chance of pregnancy.
GLP-1 medicines are not approved specifically for PCOS. Because they can affect birth control pills and should not be used in pregnancy, family planning belongs in any treatment discussion.
Why it matters
PCOS is a weight-related condition where weight loss can help symptoms, and pregnancy planning matters on a GLP-1.
Related terms
Sources
Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error